My new big pick is Odonate Therapeutics Inc (NASDAQ: ODT). The stock made an awesome move yesterday breaking out of a major resistance line with volume backed confirmation. I went long at $3.85 as it's quite possible we should see a short term move near $4.97/share. The technical chart shows a bullish sign with %K line on top of %D line and MACD rising....
Following feedback from the U.S. Food and Drug Administration (FDA) in a pre-New Drug Application meeting, Odonate Therapeutics, Inc. (NASDAQ: ODT) has concluded that the clinical data package for tesetaxel is unlikely to support FDA approval. Therefore, Odonate is discontinuing the development of tesetaxel and will wind down the operations of the Company.
As of...
